HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 282, Issue 39, 28309-28320, September 28, 2007

This Article Full Text Full Text (PDF) All Versions of this Article: 282/39/28309    most recent M703568200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Nath, A. Articles by Atkins, W. M. Search for Related Content PubMed PubMed Citation Articles by Nath, A. Articles by Atkins, W. M. Social Bookmarking                      What's this?

Ligand Binding to Cytochrome P450 3A4 in Phospholipid Bilayer Nanodiscs

THE EFFECT OF MODEL MEMBRANES^*

Abhinav Nath, Yelena V. Grinkova, Stephen G. Sligar, and William M. Atkins¹

From the Department of Medicinal Chemistry, University of Washington, Seattle, Washington 98195 and the Department of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801

The membrane-bound protein cytochrome P450 3A4 (CYP3A4) is a major drug-metabolizing enzyme. Most studies of ligand binding by CYP3A4 are currently carried out in solution, in the absence of a model membrane. Therefore, there is little information concerning the membrane effects on CYP3A4 ligand binding behavior. Phospholipid bilayer Nanodiscs are a novel model membrane system derived from high density lipoprotein particles, whose stability, monodispersity, and consistency are ensured by their self-assembly. We explore the energetics of four ligands (6-(p-toluidino)-2-naphthalenesulfonic acid (TNS), -naphthoflavone (ANF), miconazole, and bromocriptine) binding to CYP3A4 incorporated into Nanodiscs. Ligand binding to Nanodiscs was monitored by a combination of environment-sensitive ligand fluorescence and ligand-induced shifts in the fluorescence of tryptophan residues present in the scaffold proteins of Nanodiscs; binding to the CYP3A4 active site was monitored by ligand-induced shifts in the heme Soret band absorbance. The dissociation constants for binding to the active site in CYP3A4-Nanodiscs were 4.0 µM for TNS, 5.8 µM for ANF, 0.45 µM for miconazole, and 0.45 µM for bromocriptine. These values are for CYP3A4 incorporated into a lipid bilayer and are therefore presumably more biologically relevant that those measured using CYP3A4 in solution. In some cases, affinity measurements using CYP3A4 in Nanodiscs differ significantly from solution values. We also studied the equilibrium between ligand binding to CYP3A4 and to the membrane. TNS showed no marked preference for either environment; ANF preferentially bound to the membrane, and miconazole and bromocriptine preferentially bound to the CYP3A4 active site.

Received for publication, April 30, 2007 , and in revised form, June 5, 2007.

^* This work was supported by National Institutes of Health Grants GM-33775 (to S. G. S.), GM-32165, and GM-62284 (to W. M. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

¹ To whom correspondence should be addressed: Dept. of Medicinal Chemistry, Box 357610, University of Washington, Seattle, WA 91895-7610. Tel.: 206-685-0379; Fax: 206-685-3252; E-mail: winky{at}u.washington.edu.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?